Bo Lagerqvist

Summary

Affiliation: Uppsala University Hospital
Country: Sweden

Publications

  1. ncbi Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden
    Bo Lagerqvist
    Uppsala Clinical Research Center, Uppsala University Hospital, Uppsala, Sweden
    N Engl J Med 356:1009-19. 2007
  2. ncbi N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease
    Tomas Jernberg
    Department of Medical Sciences, Cardiology, Cardiothoracic Center, University Hospital, Uppsala, Sweden
    J Am Coll Cardiol 42:1909-16. 2003
  3. ncbi Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome
    Kai M Eggers
    Department of Medical Sciences, Cardiology, Uppsala University Hospital, Uppsala, Sweden
    Am Heart J 156:588-94. 2008
  4. ncbi Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden
    Stefan K James
    Department of Cardiology, Uppsala University Hospital, Uppsala, Sweden
    N Engl J Med 360:1933-45. 2009
  5. ncbi Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome
    Kai M Eggers
    Department of Medical Sciences, Cardiology, Uppsala University Hospital and Uppsala Clinical Research Centre, Uppsala, Sweden
    J Am Coll Cardiol 54:357-64. 2009
  6. ncbi Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry
    Bo Lagerqvist
    Uppsala Clinical Research Centre, Uppsala University Hospital, Uppsala, Sweden
    Circ Cardiovasc Interv 2:401-8. 2009
  7. ncbi Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome
    Kai M Eggers
    Department of Medical Sciences, Cardiology, Uppsala University Hospital and Uppsala Clinical Research Center, Uppsala, Sweden
    Circ Cardiovasc Genet 3:88-96. 2010
  8. ncbi Effects of an early invasive strategy on ischemia and exercise tolerance among patients with unstable coronary artery disease
    Erik Diderholm
    Department of Cardiology, University Hospital, Uppsala, Sweden
    Am J Med 115:606-12. 2003
  9. ncbi Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers
    Nina Johnston
    The Division of Medical Sciences, Department of Cardiology, University Hospital, Uppsala, Sweden
    Am J Cardiol 97:640-5. 2006
  10. ncbi Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention-a case-control study
    Christoph Varenhorst
    Uppsala Clinical Research Center, Department of Medical Sciences, Cardiology, Uppsala University, Sweden
    Am Heart J 162:363-71. 2011

Detail Information

Publications25

  1. ncbi Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden
    Bo Lagerqvist
    Uppsala Clinical Research Center, Uppsala University Hospital, Uppsala, Sweden
    N Engl J Med 356:1009-19. 2007
    ..Recent reports have indicated that there may be an increased risk of late stent thrombosis with the use of drug-eluting stents, as compared with bare-metal stents...
  2. ncbi N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease
    Tomas Jernberg
    Department of Medical Sciences, Cardiology, Cardiothoracic Center, University Hospital, Uppsala, Sweden
    J Am Coll Cardiol 42:1909-16. 2003
    ....
  3. ncbi Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome
    Kai M Eggers
    Department of Medical Sciences, Cardiology, Uppsala University Hospital, Uppsala, Sweden
    Am Heart J 156:588-94. 2008
    ..We now have studied the associations of persistently elevated cTnI levels to cardiac performance, inflammation, coagulation, coronary status, and treatment strategy in these patients...
  4. ncbi Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden
    Stefan K James
    Department of Cardiology, Uppsala University Hospital, Uppsala, Sweden
    N Engl J Med 360:1933-45. 2009
    ..The long-term safety and efficacy of drug-eluting coronary stents have been questioned...
  5. ncbi Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome
    Kai M Eggers
    Department of Medical Sciences, Cardiology, Uppsala University Hospital and Uppsala Clinical Research Centre, Uppsala, Sweden
    J Am Coll Cardiol 54:357-64. 2009
    ..The aim of this study was to assess risk prediction by different biomarkers in patients with an ongoing non-ST-segment elevation acute coronary syndrome (NSTE-ACS) and after clinical stabilization...
  6. ncbi Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry
    Bo Lagerqvist
    Uppsala Clinical Research Centre, Uppsala University Hospital, Uppsala, Sweden
    Circ Cardiovasc Interv 2:401-8. 2009
    ..The objective was to evaluate the role of risk factors and stent type for stent thrombosis (ST) using a large real world registry...
  7. ncbi Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome
    Kai M Eggers
    Department of Medical Sciences, Cardiology, Uppsala University Hospital and Uppsala Clinical Research Center, Uppsala, Sweden
    Circ Cardiovasc Genet 3:88-96. 2010
    ..This study assessed the time course and the long-term prognostic relevance of GDF-15 levels measured repetitively in patients with non-ST-segment-elevation acute coronary syndrome during 6 months after the acute event...
  8. ncbi Effects of an early invasive strategy on ischemia and exercise tolerance among patients with unstable coronary artery disease
    Erik Diderholm
    Department of Cardiology, University Hospital, Uppsala, Sweden
    Am J Med 115:606-12. 2003
    ..An early invasive approach after an episode of unstable coronary artery disease has beneficial effects on mortality and myocardial infarction, but its effects on exercise capacity and ischemia have not been investigated...
  9. ncbi Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers
    Nina Johnston
    The Division of Medical Sciences, Department of Cardiology, University Hospital, Uppsala, Sweden
    Am J Cardiol 97:640-5. 2006
    ....
  10. ncbi Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention-a case-control study
    Christoph Varenhorst
    Uppsala Clinical Research Center, Department of Medical Sciences, Cardiology, Uppsala University, Sweden
    Am Heart J 162:363-71. 2011
    ..On-clopidogrel platelet reactivity was investigated in patients with previous angiographically confirmed STh, myocardial infarction (MI), and controls...
  11. ncbi Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery disease
    Nina Johnston
    Department of Medical Sciences, Cardiology, Cardiothoracic Center, University Hospital, Uppsala, Sweden
    Am Heart J 152:1052-8. 2006
    ..Few studies have investigated the effects of an early revascularization in relation to renal function in patients with unstable coronary artery disease (CAD)...
  12. ncbi Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry)
    Axel Akerblom
    Department of Cardiology, UppsalaClinical Research Center, Uppsala University, Uppsala, Sweden
    J Am Coll Cardiol 56:470-5. 2010
    ..The aim of this study was to test the noninferiority of eptifibatide relative to abciximab in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI)...
  13. ncbi Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
    Giovanna Sarno
    Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden
    Eur Heart J 33:606-13. 2012
    ..To compare the long-term outcome after percutaneous coronary intervention with 'new-generation' drug-eluting stents (n-DES) to 'older generation' DES (o-DES), and bare-metal stents (BMS) in a real-world population...
  14. ncbi Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction
    Kristina Dunder
    Department of Public Health and Caring Sciences Geriatrics, Uppsala University, Uppsala, Sweden
    Am Heart J 147:502-8. 2004
    ..This study compared baseline risk factors between subjects in whom stable angina pectoris developed and subjects in whom unheralded fatal or nonfatal MI developed during the follow-up period...
  15. ncbi Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes
    Anders Malarstig
    Division of Clinical Chemistry, Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Arterioscler Thromb Vasc Biol 25:2667-72. 2005
    ..Moreover, we wanted to investigate the impact of associated TF SNPs on mRNA production in human monocytes...
  16. ncbi A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study
    Bo Lagerqvist
    Department of Cardiology, University Hospital, Uppsala, Sweden
    J Am Coll Cardiol 40:1902-14. 2002
    ..We sought to report the first and repeat events and to separate spontaneous and procedure-related events over two years in the Fast Revascularization during InStability in Coronary artery disease (FRISC-II) invasive trial...
  17. ncbi The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy
    Erik Diderholm
    Department of Cardiology, University Hospital, Uppsala, Sweden
    Am Heart J 143:760-7. 2002
    ....
  18. ncbi Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality
    Kai M Eggers
    Department of Medical Sciences, Cardiology, University Hospital Uppsala, S 751 85 Uppsala, Sweden
    Circulation 116:1907-14. 2007
    ..However, the prevalence and prognostic importance of persistent troponin elevation in stabilized patients after an episode of non-ST-elevation acute coronary syndrome are unknown and were therefore assessed in this study...
  19. ncbi Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment
    Lene Holmvang
    The Heart Center 2141, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100 Copenhagen Ø, Denmark
    J Am Coll Cardiol 41:905-15. 2003
    ..The present study is a sub-study of the previously published Fast Revascularization during InStability in Coronary artery disease trial (FRISC-II)...
  20. ncbi Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization
    Anna Norhammar
    Department of Cardiology, Karolinska Hospital, Stockholm, Sweden
    J Am Coll Cardiol 43:585-91. 2004
    ..This study was designed to study the influence of diabetes on the outcome of unstable coronary artery disease (CAD)...
  21. ncbi Consideration of the total ST-segment deviation on the initial electrocardiogram for predicting final acute posterior myocardial infarct size in patients with maximum ST-segment deviation as depression in leads V1 through V3. A FRISC II substudy
    Rasmus S Ripa
    Division of Cardiology, Duke University Medical Center, Durham, NC 27705, USA
    J Electrocardiol 38:180-6. 2005
    ..The formula derived could be valuable for selecting patients who fail to meet strict ST-elevation AMI criteria for emergency intravenous or intracoronary reperfusion therapy...
  22. ncbi Oxidized low-density lipoprotein as a predictor of outcome in patients with unstable coronary artery disease
    Nina Johnston
    Department of Medical Sciences, Cardiology, Cardiothoracic Center, University Hospital, 751 85 Uppsala, Sweden
    Int J Cardiol 113:167-73. 2006
    ..The prognostic value of circulating oxidized low-density lipoprotein (OxLDL) in patients with unstable coronary artery disease (CAD) is unknown...
  23. ncbi 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study
    Bo Lagerqvist
    Department of Cardiology and Uppsala Clinical Research Center, University Hospital, S-751 85 Uppsala, Sweden
    Lancet 368:998-1004. 2006
    ..INTERPRETATION: The 5-year outcome of this trial indicates sustained benefit of an early invasive strategy in patients with non-ST-elevation acute coronary syndrome at moderate to high risk...
  24. ncbi Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis
    Michelle O'Donoghue
    TIMI Study Group, Brigham and Women s Hospital, 350 Longwood Ave, First Floor, Boston, MA 02115, USA
    JAMA 300:71-80. 2008
    ..Although an invasive strategy is frequently used in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS), data from some trials suggest that this strategy may not benefit women...
  25. ncbi Outcome of percutaneous coronary intervention in hospitals with and without on-site cardiac surgery standby
    Jorg Carlsson
    Department of Internal Medicine, Division of Cardiology, Lanssjukhuset, Kalmar, Sweden
    Heart 93:335-8. 2007
    ..To compare characteristics and outcome of patients undergoing percutaneous coronary intervention (PCI) in clinics with (WSB) or without (NOSB) on-site cardiac surgery backup...